Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 22]
Step forward for cancer treatment
Wednesday, 21 November 2007, 4:16 pm | PHARMAC
Cancer treatment is taking a significant step forward with PHARMAC and District Health Boards approving funding for three further cancer medicines. More >>
Step forward for cancer treatment
Wednesday, 21 November 2007, 10:23 am | PHARMAC
Cancer treatment is taking a significant step forward with PHARMAC and District Health Boards approving funding for three further cancer medicines. More >>
Committed to action on Stakeholder Survey
Monday, 12 November 2007, 11:48 am | PHARMAC
A survey of stakeholders of the Government drug-funding agency PHARMAC has identified areas for PHARMAC to work on to improve how it is perceived, acting chief executive Matthew Brougham says. More >>
BSA Herceptin decision underlines need for balance
Monday, 1 October 2007, 10:00 am | PHARMAC
PHARMAC is welcoming the outcome of a complaint it made to the Broadcasting Standards Authority about an unbalanced and inaccurate TV3 60 Minutes programme. More >>
Ritalin SR to be funded for some patients
Thursday, 27 September 2007, 1:43 pm | PHARMAC
PHARMAC is providing funded access to the Ritalin SR brand of methylphenidate for those people who have experienced clinical difficulties in changing to Rubifen SR, another brand of methylphenidate. More >>
Christchurch GP welcomed onto PHARMAC Board
Tuesday, 25 September 2007, 11:18 am | PHARMAC
PHARMAC Board chairman Richard Waddel is welcoming the appointment of Christchurch GP David Kerr to the Board of the Government drug-funding agency. More >>
Step forward for access to off-patent medicines
Friday, 14 September 2007, 3:17 pm | PHARMAC
People will be able to more easily access some off-patent medicines, if changes proposed by Government drug-funding agency PHARMAC are adopted. More >>
Corrected data on antidepressant prescribing
Thursday, 13 September 2007, 9:40 am | PHARMAC
PHARMAC has completed further analysis of data on the prescribing of antidepressants, and revised down very considerably the numbers of preschool children being prescribed antidepressants. More >>
New breast cancer drug funded
Monday, 13 August 2007, 9:24 am | PHARMAC
Women with breast cancer have another funded drug treatment available, with the aromatase inhibitor drug exemestane (Aromasin) funded from August 1. Aromatase inhibitors can help block the growth of hormone-dependent tumours by lowering the amount of the ... More >>
PHARMAC funds another antipsychotic drug
Friday, 10 August 2007, 11:12 am | PHARMAC
People with schizophrenia and related psychoses have a new funded treatment available. More >>
Novartis secure vital heart injection
Saturday, 4 August 2007, 5:02 pm | PHARMAC
PHARMAC and pharmaceutical company Novartis have reached an agreement to secure supplies of the heart medicine metoprolol tartrate injection. More >>
AstraZeneca holds patients to ransom
Tuesday, 31 July 2007, 10:40 am | PHARMAC
It is not acceptable for AstraZeneca to gamble with the lives of acutely ill patients in order to protect itself from competition. AstraZeneca has written to medical professionals blaming PHARMAC for AstraZeneca’s decision to withdraw supply of Betaloc injection, ... More >>
Hypoglycaemia risk with Accu-Chek Performa strips
Friday, 6 July 2007, 3:02 pm | PHARMAC
PHARMAC is working with Roche Diagnostics and Medsafe to address a potential health issue for people using the Accu-Chek Performa blood glucose strips. More >>
Updated guide promotes better understanding
Thursday, 28 June 2007, 11:24 am | PHARMAC
Publishing an updated guide to PHARMAC’s economic analysis framework will help people better understand its drug assessment processes, the Government drug-funding agency says. More >>
Decision helps respiratory patients breathe easier
Tuesday, 26 June 2007, 12:09 am | PHARMAC
PHARMAC is investing almost $10 million over the next five years to make a drug for chronic respiratory disease available to more New Zealanders. Deputy Medical Director Dr Dilky Rasiah says from July 1 more people with diseases such as chronic bronchitis ... More >>
PHARMAC Subsidy Means Cancer Treatment Convenience
Sunday, 17 June 2007, 6:56 pm | PHARMAC
An estimated 450 people per year with colorectal cancer will have access to more convenient treatment from July 1 following a decision by PHARMAC. Dr Moodie says the decision will cost at least $1.7 million a year. More >>
Recall of Viracept (Nelfinavir)
Friday, 8 June 2007, 5:03 pm | PHARMAC
Pharmaceutical company Roche is taking responsible action with its voluntary recall of the anti-HIV treatment nelfinavir (Viracept), says government drug-funding agency PHARMAC. More >>
$21m savings for migraine medicines
Thursday, 24 May 2007, 2:17 pm | PHARMAC
People needing relief for migraine attacks will have a choice of fully funded treatments as a result of a new move by PHARMAC that will also save more than $20 million. More >>
Building a culture of medicine safety
Thursday, 17 May 2007, 9:30 am | PHARMAC
A culture of safety around medicines and reducing medication errors are two of the key themes for a two-day workshop in Wellington this week. More >>
350 women each year benefit on Herceptin decision
Thursday, 3 May 2007, 10:38 am | PHARMAC
About 350 women are set to benefit each year from the decision to fund Herceptin for early HER2-positive breast cancer. Funding will be available from 1 July this year in a move that represents an investment of $6 million per year by District Health ... More >>
